CoChat

Apolipoprotein A‐I: Insights from redox proteomics for its role in neurodegeneration

Open access
Keeney, Jeriel T. R., Swomley, Aaron M., Förster, Sarah, Harris, Jessica L., Sultana, Rukhsana, Butterfield, D. Allan · 2013 · PROTEOMICS – Clinical Applications
Cited by 72

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Proteomics has a wide range of applications, including determination of differences in the proteome in terms of expression and post‐translational protein modifications. Redox proteomics allows the identification of specific targets of protein oxidation in a biological sample. Using proteomic techniques, apolipoprotein A‐I(Apo A‐I) has been found at decreased levels in subjects with a variety of neurodegenerative disorders including in the serum and cerebrospinal fluid (CSF) of A lzheimer disease (AD),P arkinson disease (PD), and D own syndrome (DS) with gout subjects.A po A‐I plays roles in cholesterol transport and regulation of inflammation. Redox proteomics further showed A po A‐I to be highly oxidatively modified and particularly susceptible to modification by 4‐hydroxy‐2‐trans‐nonenal (HNE), a lipid peroxidation product. In the current review, we discuss the consequences of oxidation of A po A‐I in terms of neurodegeneration.ROS‐associated chemotherapy related A po A‐I oxidation leads to elevation of peripheral levels of tumor necrosis factor‐α (TNF‐α) that can cross the blood‐brain barrier (BBB) causing a signaling cascade that can contribute to neuronal death, likely a contributor to what patients refer to as “chemobrain.” Current evidence suggests A po A‐I to be a promising diagnostic marker as well as a potential target for therapeutic strategies in these neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/prca.201200087

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 72

Metadata

Authors
Keeney, J. T. R., Swomley, A. M., Förster, S., Harris, J. L., Sultana, R., & Butterfield, D. A.
Venue
PROTEOMICS – Clinical Applications
Publisher
Wiley
Published
2013-01
Volume
7
Issue
1-2
Pages
109-122
ISSN
  • 1862-8346 (ISSN-L)
  • 1862-8354
OpenAlex
W2000744762
Cited by
72
References
29
FWCI
2.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.